SYMBRAHALE
"SYMBRAHALE" is a word mark owned by AstraZeneca AB, filed at the USPTO on May 12, 2022. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since January 7, 2025
- Filed
- May 12, 2022
- Registered
- January 7, 2025
- Priority date
- May 10, 2022
- Claimed from European Union
- Application no.
- 97408274
- Registration no.
- 7637317
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns SYMBRAHALE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
AstraZeneca AB
Södertälje, Sweden
Representative
Cara M. Kearney
Astrazeneca Pharmaceuticals LP
What the mark covers
The products and services SYMBRAHALE is filed for, grouped by Nice class.
Pharmaceutical preparations and substances for the treatment of diseases and disorders of the respiratory systems
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- 1(b) basis deleted; proceed to registration
- Notice of allowance cancelled
- Teas delete 1(b) basis received
- Noa e-mailed - sou required from applicant
- Extension of time to oppose process - terminated
- Extension of time to oppose process - terminated
- Post publication amendment - entered
- Assigned to petition staff
10 earlier steps on the official record.
About SYMBRAHALE
Who owns the trademark "SYMBRAHALE"?
The USPTO trademark "SYMBRAHALE" (application 97408274) is owned by AstraZeneca AB.
What is the status of "SYMBRAHALE"?
Its status at the USPTO is: registered.
When was "SYMBRAHALE" registered?
It was registered on January 7, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull SYMBRAHALE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a8a-8994-773a-8ae1-b64c5606b70d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a8a-8994-773a-8ae1-b64c5606b70d",
"object": "trademark",
"mark_text": "SYMBRAHALE",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97408274",
"filing_date": "2022-05-12",
"nice_classes": [
5
],
"owners": [
{
"name": "AstraZeneca AB",
"entity_id": "ent_019eb700-571d-718e-bf3d-80fe37712629"
}
]
}